Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine

被引：4
|
作者：
Tomova, A.
Brodowicz, T.
Tzekova, V.
Timcheva, C.
Wiltschke, C.
Gerges, D. A.
Pawlega, J.
Spanik, S.
Inbar, M. J.
Zielinski, C. C.
机构：
[1] Plovdiv Canc Ctr, Plovdiv, Bulgaria
[2] Univ Vienna, Dept Med 1, Vienna, Austria
[3] Univ Hosp, Sofia, Bulgaria
[4] SBALO Natl Oncol Ctr, Sofia, Bulgaria
[5] Rizk Hosp, Beirut, Lebanon
[6] Klin Onkol CmuJ, Krakow, Poland
[7] Onkol Ustav Sv Alzbety, Bratislava, Slovakia
[8] Sourasky Med Ctr, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.1106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1106
引用
收藏
页数：1
相关论文
共 50 条
  • [31] SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel gemcitabine as first-line chemotherapy for ovarian cancer
    Vasey, PA
    Atkinson, R
    Osborne, R
    Parkin, D
    Symonds, R
    Paul, J
    Lewsley, L
    Coleman, R
    Reed, NS
    Kaye, S
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2006, 94 (01) : 62 - 68
  • [32] Gemcitabine/docetaxel - Welcome to a new standard
    Fleming, Gini
    GYNECOLOGIC ONCOLOGY, 2008, 109 (03) : 313 - 315
  • [33] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Karapanagiotou, Eleni M.
    Charpidou, Adrianni
    Tzannou, Ifigenia
    Dilana, Kalliopi
    Kotteas, Elias
    Tourkantonis, Ioannis
    Kosmas, Epaminondas
    Provata, Aspasia
    Syrigos, Kostas
    MEDICAL ONCOLOGY, 2008, 25 (03) : 303 - 308
  • [34] GEMCITABINE-DOCETAXEL FOR PEDIATRIC SARCOMA
    Mora, Jaume
    Cruz, Ofelia
    Parareda, Andreu
    Salvador, Hector
    Lopez, Estibaliz
    Cardesa, Teresa
    de Torres, Carmen
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 931 - 932
  • [35] Docetaxel and gemcitabine released for cancer chemotherapy
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (14) : 1643 - &
  • [36] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Eleni M. Karapanagiotou
    Adrianni Charpidou
    Ifigenia Tzannou
    Kalliopi Dilana
    Elias Kotteas
    Ioannis Tourkantonis
    Epaminondas Kosmas
    Aspasia Provata
    Kostas Syrigos
    Medical Oncology, 2008, 25 : 303 - 308
  • [37] Treatment of Disseminated Paraganglioma With Gemcitabine and Docetaxel
    Mora, Jaume
    Cruz, Ofelia
    Parareda, Andreu
    Sola, Teresa
    de Torres, Carmen
    PEDIATRIC BLOOD & CANCER, 2009, 53 (04) : 663 - 665
  • [38] Docetaxel (Taxotere) and gemcitabine in combination therapy
    Rizvi, NA
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 19 - 22
  • [39] Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for advanced upper-tract urothelial cancer patient with impaired renal function
    Yoneyama, T.
    Tanaka, T.
    Narita, T.
    Oikawa, M.
    Hagiwara, K.
    Yoneyama, T.
    Imai, A.
    Hatakeyama, S.
    Hashimoto, Y.
    Koie, T.
    Ohyama, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [40] Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
    Joensuu, H.
    Sailas, L.
    Alanko, T.
    Sunela, K.
    Huuhtanen, R.
    Utriainen, M.
    Kokko, R.
    Bono, P.
    Wigren, T.
    Pyrhonen, S.
    Turpeenniemi-Hujanen, T.
    Asola, R.
    Leinonen, M.
    Hahka-Kemppinen, M.
    Kellokumpu-Lehtinen, P.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 968 - 973
12345